Denise has more than 30 years of leadership experience in sales, product management, new business development, national accounts, and medical economics. This experience was gained in roles with biopharmaceutical and healthcare consulting industries, including Pfizer, Bristol-Myers Squibb, AMGEN, and Covance Health Economics and Outcome Services. She possesses extensive knowledge of hospital inpatient/outpatient and physician office reimbursement systems, having effectively positioned novel drugs, devices, and services with payers in each setting.
Denise's expertise is in injectable drugs and biologics, such as those used in oncology, dialysis, congestive heart failure, and rare diseases. These drugs often have a higher cost to the healthcare system and subsequently are under increased payer scrutiny. She has successfully created and executed strategic reimbursement plans for patient access to specialty drugs, as well as novel technologies for age-related macular degeneration, allergy, and cancer testing methodologies. Clients have commented that Denise has a knack for clearly understanding their need to pinpoint strategic recommendations that are executable and that link to specific outcomes.
Denise works with medical specialty societies, educating physicians on opportunities for collaboration with payers to develop positive coverage for drugs, devices, and services. She has effectively partnered physician groups with payers to affect coverage decisions that support physician discretion regarding diagnostic and treatment decisions.
Denise is also a well-known author and speaker on the complexities of reimbursement in specific disease areas. Examples of societies tapping into Denise's expertise include:
Denise received her Bachelor of Science degree from Fairleigh Dickinson University in New Jersey.